Moreover, 133 (45.08%) of the 295 triple-negative breast cancers showed periostin expression compared to 201 (25.74%) of the 781 cases of non-triple-negative breast cancers (P = 0.001) (Fig. 4E and F). Here, POSTN is linked to triple-negative breast carcinoma.